| Date | Form | Description | Docs | XBRL | Pages |
| 03/16/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 08/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 05/20/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
34 |
| 02/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
30 |
| 08/18/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
37 |
| 05/22/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
44 |
| 03/09/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
39 |
| 09/15/14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
66 |
| 06/16/14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
63 |
| 03/17/14 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
74 |
Latest News & Events
Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds
Read More...Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline
Read More...Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays
Read More...